Find the Perfect Plan for Your Investment Journey
P
Latest price
52 Week Range
€16.50 - €21.90
Next Earnings Date
Jun 28 2025 (Estimate)
Next Earnings Date
Jun 28 2025 (Est.)
Latest price
Market Cap | €866.23M |
EV | €815.53M |
Shares Outstanding | 40.29M |
Beta | 0.11 |
Analyst Rating | BUY |
Analyst Target Price | €26.00 |
P/E 2025E | 9.77x |
P/Revenue 2025E | 5.09x |
Revenue | 150.10% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 11.60% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | -27.27% |
ROE 2025E | - |
ROCE 2024 | 39.51% |
DPS 2025E | €0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
P
Philogen S.p.A.
PHIL
Sector
Healthcare
Industry
Biotechnology
CEO
Neri, Dario
Employees
174
Website
www.philogen.comIPO Date
2021-03-03
Headquarters
Piazza La Lizza #7, Siena, Siena, 53100, Italy
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved